0001415889-23-002174.txt : 20230208 0001415889-23-002174.hdr.sgml : 20230208 20230208181020 ACCESSION NUMBER: 0001415889-23-002174 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230207 FILED AS OF DATE: 20230208 DATE AS OF CHANGE: 20230208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Verwijs Marinus CENTRAL INDEX KEY: 0001916553 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40544 FILM NUMBER: 23600343 MAIL ADDRESS: STREET 1: C/O AEROVATE THERAPEUTICS, INC. STREET 2: 200 BERKELEY STREET, FLOOR 18 CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc. CENTRAL INDEX KEY: 0001798749 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831377888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-443-2400 MAIL ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-02082023_060211.xml X0306 4 2023-02-07 0001798749 Aerovate Therapeutics, Inc. AVTE 0001916553 Verwijs Marinus C/O AEROVATE THERAPEUTICS, INC. 930 WINTER STREET, SUITE M-500 WALTHAM MA 02451 false true false false SENIOR VICE PRESIDENT, CMC Stock Option (Right to Buy) 25.57 2023-02-07 4 A 0 62000 0 A 2033-02-06 Common Stock 62000 62000 D The option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on March 7, 2023. /s/ George A. Eldridge, Attorney-in-Fact 2023-02-08